Multiplikator Forward P/S: Venus Concept (VERO)
Venus Concept Inc. (VERO) generates revenue through the leasing and sale of aesthetic systems for beauty clinics. The forward price-to-sales ratio on the GURU.Markets chart illustrates the current market valuation, where 0.00 describes the current status of the metric. However, high demand cyclicality and debt load issues coupled with low production efficiency limit the growth potential of the business value.
Ringkesan rincian data analitis Venus Concept Corporation (VERO)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Venus Concept Inc.|VERO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Venus Concept Inc.|VERO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Venus Concept Corporation|VERO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Venus Concept|Rasio cepet venusconcept.com
- rincian asil keuangan lan kelipatan valuasi:
VERO - Penghasilan resik perusahaan|Bathi sing dikarepake Venus Concept Inc.|VERO - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Venus Concept Corp|VERO - Pangali PEG|Pangali EV/EBITDA Venus Concept Corporation|VERO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Venus Concept|VERO - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan venusconcept.com|VERO - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Venus Concept Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:VERO (Venus Concept)
Amidst the restructuring of supply chains and the switching of vendors, it is critical to track the forward P/S multiple for Venus Concept Inc. (VERO) to assess revenue sustainability. This indicator compares current market capitalization with projected annual sales, allowing investors to determine the asset's degree of overvaluation and evaluate business liquidity relative to expected cash flows.
Karo sapa Venus Concept Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS (ibs.inc) - Multiplikator forward rega marang pendapatan|XAIR (Beyond Air) - Rasio rega marang prakiraan pendapatan|PFSA (Profusa) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep STRATA Skin SSKN|Rasio rega marang prakiraan pendapatan GlucoTrack (GCTK)|NanoVibronix Inc. - Kapitalisasi marang prakiraan pendapatan|Nuwellis, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S aethlonmedical.com AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Avinger Inc. AVGR|BSGM (BioSig Technologies, Inc) - Multiplikator forward rega marang pendapatan|Cutera Inc - Rega forward marang dodolan|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan inarimedical.com (NARI)|Rasio rega marang prakiraan pendapatan Nevro (NVRO)|RSLS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
